Commentary

Dispelling four myths about the FDA


 

References

Myth 4: The FDA regulates the practice of medicine.

FACT: The FDA regulates the approval of a drug, but not how it is prescribed. Doctors are permitted to prescribe a drug for any reason they think is medically appropriate.

The FDA creates the “drug label” in conjunction with the drug company to ensure that promotional claims are not false or misleading. The drug label of FDA-approved drugs provides information about the drug, including the approved doses and how the drug should be given to treat the medical condition for which it was approved.

However, physicians often use drugs in a way that is different from that described in the FDA-approved drug label, an “off-label” use. This can mean that the drug is:

• Used for a different disease or medical condition.

• Given in a different way (such as by a different route).

• Given in a different dose.

Off-label is also called “nonapproved” or “unapproved” use of a drug. Because drug makers have not put their drugs through the studies required by the FDA to officially approve the drug for new uses, new uses for these drugs should be taken with caution as the FDA has not reviewed the clinical evidence to support the new use. Any off-label drug usage should include a detailed conversation between physician and patient.4

Dr. John J. Whyte is the director of Professional Affairs and Stakeholder Engagement (PASE) in the FDA’s Center for Drug Evaluation and Research (CDER).

Pages

Recommended Reading

Small businesses snub Obamacare’s SHOP exchange
MDedge Rheumatology
Supreme Court agrees to hear ACA contraceptive mandate opt-out challenge
MDedge Rheumatology
Senate panel targets drug prices during FDA commissioner nomination hearing
MDedge Rheumatology
UnitedHealth warns of marketplace exit: Start of a trend or push for White House action?
MDedge Rheumatology
After 3 years of decline, hospital injury rates plateau, report finds
MDedge Rheumatology
Health spending growth soars after years of low growth
MDedge Rheumatology
Senate votes to gut ACA, defund Planned Parenthood
MDedge Rheumatology
Cigna CEO David Cordani: ACA marketplace is still in ‘version 1.0’
MDedge Rheumatology
NIH, CDC get boost in House budget bill
MDedge Rheumatology
ACA marketplace sees late surge in new enrollees
MDedge Rheumatology